Body composition, cardiovascular risk factors and liver function in long term androgenic-anabolic steroids using bodybuilders three months after drug withdrawal

International Journal of Sports Medicine

Volumn 17, Issue 6, 1996, Pages 429-433

  Hartgens, F ^a   Kuipers, H ^b   Wijnen, J A G ^c   Keizer, H A ^b  

^a Netherlands Ctr for Doping Affairs   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Blood pressure; Body composition; Bodybuilders; Circumferences; Lipoproteins; Liver enzymes; Muscle fiber

Indexed keywords

ALKALINE PHOSPHATASE; ANABOLIC AGENT; ANDROGEN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER ENZYME; TRIACYLGLYCEROL;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BODY BUILDING; BODY COMPOSITION; BODY HEIGHT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; DRUG WITHDRAWAL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LEAN BODY WEIGHT; LIVER FUNCTION; MALE; MUSCLE BIOPSY; MUSCLE CELL; NORMAL HUMAN; RISK FACTOR; SKINFOLD THICKNESS; SYSTOLIC BLOOD PRESSURE; TRAINING; VASTUS LATERALIS MUSCLE;

EID: 0029792307     PISSN: 01724622     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-972873     Document Type: Article

References (30)

1. Alén M.: Androgenic steroid effects on liver and red cells. Br J Sports Med 19: 15-20, 1985.
2. Alén M., Häkkinen K.: Physical health and fitness of an elite bodybuilder during 1 year of self-administration of testosterone and anabolic steroids: a case study. Int J Sports Med 6: 24-29, 1985.
3. Alén M., Häkkinen K., Komi P. V.: Changes in neuromuscular performance and muscle fiber characteristics of elite power athletes self-administering androgenic and anabolic steroids. Acta Physiol Scand 122: 535-544, 1984.
4. Alén M., Rahkila P., Marniemi J.: Serum lipids in power athletes self-administering testosterone and anabolic steroids. Int J Sports Med 6: 139-144, 1985.
5. Bahrke M. S., Yesalis C. E., Wright J. E.: Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males. Sports Med 10: 303-337, 1990.
6. Bamman M. M., Hunter G. R., Newton L. E., Roney R. K., Kahled M. A.: Changes in body composition, diet, and strength of body-builders during the 12 weeks prior to competition. J Sports Med Phys Fitness 33: 383-391, 1993.
7. Cohen J. C., Noakes T. D., Spinnler Benade A. J.: Hypercholesterolemia in male power lifters using anabolic-androgenic steroids. Physician Sports Med 16: 49-56, 1988.
8. Dubowitz V.: Muscle Biopsy: A Practical Approach. Philadelphia, Bailliere Tindall, 1985, pp 86-90.
9. Elvers J. W. H.: Geautomatiseerd voedingsonderzoek, GVOP, Nijmegen. GVO-projekt, KU, Nijmegen, 1980 (Dutch).
10. Freed D. L. J., Banks A. J., Longson D., Burley D. M.: Anabolic steroids in athletics: Cross-over double blind trial on weight lifters. Br Med J 2: 471-473, 1975.
11. Griggs R. C., Kingston W., Jozefowicz R. F., Herr B. E., Forbes G., Halliday D.: Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol 66: 498-503, 1989.
12. Häkkinen K., Alén M.: Physiological performance, serum hormones, enzymes and lipids of an elite power athlete during training with and without androgens and during prolonged detraining. J Sports Med Phys Fitness 26: 92-100, 1986.
13. Haupt H. A., Rovere G. D.: Anabolic Steroids: a review of the literature. Am J Sports Med 12: 469-484, 1984.
14. Hervey G. R., Hutchinson I., Knibbs A. V., Burkinshaw L., Jones P. R. M., Norgan N. G., Levell M. J.: "Anabolic" effects of methandienone in men undergoing athletic training. Lancet 2: 699-702, 1981.
15. Hickson J. F., Johnson T. E., Lee W., Sidor R. J.: Nutrition and the precontest preparations of a male bodybuilder. J Am Diet Assoc 90: 264-267, 1990.
16. Holma P.: Effect of an anabolic steroid (methandienone) on central and peripheral blood flow in well-trained male athletes. Ann Clin Res 9: 215-221, 1977.
17. Hosegood J. L., Franks A. J.: Response of human skeletal muscle to the anabolic steroid stanozolol. Br Med J 297. 1028-1029, 1988.
18. 2-cholesterol and increase hepatic triglyceride lipase activity. Med Sci Sports Exerc 17: 462-465, 1985.
19. Kleiner S. M., Calabrese L. H., Fielder K. M., Naito H. K., Skibinski C. I.: Dietary influences on cardiovascular disease risk in anabolic steroid-using and nonusing bodybuilders. J Am Coll Nutr 8: 109-119, 1989.
20. Kuipers H., Wijnen J. A. G., Hartgens F., Willems S. M. M.: Influence of anabolic steroids on body composition, blood pressure, lipid profile, and liver functions in body-builders. Int J Sports Med 12: 413-418, 1991.
21. Lenders J. W. M., Demacker P. N. M., Vos J. A., Janssen P. L. M., Hoitsma A. J., van 't Laar A., Thien T.: Deleterious effects of anabolic steroid son serum lipoproteins, blood pressure, and liver function in amateur bodybuilders. Int J Sports Med 9: 19-23, 1988.
22. MacDougall J. D., Sale D. G., Elder G., Sutton J. R.: Muscle ultrastructural characteristics of elite power lifters and body builders. Eur J Appl Physiol 48: 117-126, 1982.
23. Müller R., Hollmann W.: Akute Lipoproteinbeeinflussung durch ein anaboles Steroid bei Kraftsportlern. Deutsche Zeitschrift für Sportmedizin 39 (Sonderheft): 35-40, 1988.
24. Roukonen A., Alén M., Bolton N., Vihko R.: Response of serum testosterone and its precursor steroids, SHBG and CBG to anabolic steroid and testosterone self-administration in man. J Steroid Biochem 23: 33-38, 1985.
25. Strømme S. B., Meen H. D., Aakvaag A.: Effects of an androgenic-anabolic steroid on strength development and plasma testosterone levels in normal males. Med Sci Sports Exerc 6: 203-208, 1974.
26. Tesch P., Larsson L.: Muscle hypertrophy in bodybuilders. Eur J Appl Physiol 49: 301-306, 1982.
27. Tesch P. A., Thorsson A., Essén-Gustavsson B.: Enzyme activities of FT and ST muscle fibers in heavy-resistance trained athletes. J Appl Physiol 67: 83-87, 1989.
28. Thompson P. D., Cullinane E. M., Sady S. P., Chenevert C., Saritelli A. L., Sady M. A., Herbert P. N.: Contrasting effects of testosterone and stanozolol on serum protein levels. JAMA 261: 1165-1168, 1989.
29. Wilson J. D.: Androgen abuse by athletes. Endocrine Rev 9: 181-199, 1988.
30. Wright B. M., Dore C. F.: Random-zero sphygmomanometer. Lancet i: 337-338, 1970.